Repost, $LLBO FULL DD REPORT- EVERYTHING YOU

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz
Repost,

$LLBO FULL DD REPORT- EVERYTHING YOU NEED



51.06% of Monday's beautiful trading volume composed of aproximately 60 MILLION shares shorted...

Friday's Short Volume (some of which still remains uncovered)- : 57.5 MILLION SHARES

OTC SHORT REPORT LINK : http://otcshortreport.com/index.php?index=LLBO#.VQeb5V6LQds

The only reason we didn't close up atleast 50% is due to that massive shorting at the end. I'd estimate 90% of the sells Monday were directly due to shorters.


ARE THESE GUYS FRICKING NUTS LMAO?? MASSIVE SHORT SQUEEZE COMING...THESE GUYS HAVE TO COVER... BUYING PRESSURE + SHORT SQUEEZE = COPPER-SILVER LAND



1) Stanford University Canary Center for Early Cancer Detection has pledged $187,000 to help fund the equipment for the trials at El Camino Hospital.

2 )Detected, a documentary movie about the journey to market of the iTBra™ was commissioned and paid for by Cisco Systems and will premiere at the SxSW Technology and Film Festival in Austin Texas next week, 3/16.

LINK TO AMAZING DETECTED TRAILER:: http://newsroom.cisco.com/video-content?type=...Id=1611072

LINK TO CISCO TWEETS ABOUT CIRCADIA AND THE MOVIE DETECTED (470K FOLLOWERS):
https://twitter.com/Cisco/status/577511348424167424
https://twitter.com/detectedmovie/status/577541555449364480
https://twitter.com/Cisco/status/577546373572239360


-4 DOCTORS WITH OUTSTANDING CREDENTIALS HAVE WORKED TO DEVELOPED THIS REVOLUTIONARY PRODUCT! (STANFORD GRAD, TOP 1% SURGEON IN THE WORLD)

LINK: CIRCADIA'S RESEARCH AND DEVELOPMENT TEAM: http://cyrcadiahealth.com/medical-advisory-board/

CYRCADIA BREAST-CANCER PREVENTION DEVICE RESULTS:

CLINICAL TRIALS:


Over 500 women tested in previous clinical trials achieved promising results in sensitivity, specificity and accuracy at 87% correlation to cancer, when compared to mammography’s 83% correlation. The studies also indicated improved outcomes for the Cyrcadia Health solution in difficult to image (dense breast tissue) patient populations. Cyrcadia Health is preparing for a multi-site final validation clinical study to be conducted in leading US and Asia cancer hospitals in late 2014. Cyrcadia Health intends to show equal to improved results to mammography in the general population with improved results over todays “gold standards” in the dense tissue population, which entails over 60% of all women under, and 40% over the age of 40. Our comfortable, non-compressive and non-irradiative approach will help to populate a global “big data” core library on phenotype/genotype, and demographic variables contributing to the state of breast cancer on a worldwide basis.


4% MORE EFFECTIVE THAN THE MODERN DAY TREATMENT + COST EFFECTIVE AND EARLY PREVENTION BENEFITS

MEDICAL ECONOMICS:
The Cyrcadia Health solution is a cost effective system that through early screening and detection can improve patient outcomes, reduce healthcare costs, improve surgical decision processes, and is a patient-friendly solution for breast screening.


FLEXTRONICS IS INVESTED IN CYRCADIA'S REVOLUTIONARY PRODUCT ($7BILLION DOLLAR INVESTMENT FIRM)

FLEX STOCK: http://investors.flextronics.com/faq.cfm

CYRCADIA HEALTH SOLUTIONS PARTNERS LINK: http://cyrcadiahealth.com/partners/


4) The ECH trial is slated for start before the end of April 2015. The trials are expected to be completed in four to 6 months. On completion Cyrcadia will obtain CE Marking allowing for sales and marketing outside of the USA. On completion of the trials Cyrcadia will be submitting a 510(k) to the FDA. Post clearance, marketing will begin in the USA.

5)It is interesting to note that Dr. Farrar at OSU will be the primary investigator for the trials conducted at OSU. Dr. Farrar headed the original "proof of concept" study that was conducted at OSU. Dr. Farrar published on the results of this study, commenting on the potential of this lifesaving technology that could assist in the early detection of breast tissue abnormalities and breast cancers.

DO YOU REALLY THINK THEY WONT PASS THE TRAILS LOL? NO WAY

$LLBO is Cyrcadia's largest shareholder, at approximately 40% via a 10 million dollar investment

LLBO owns 40% of Cyrcadia Health who’s product line is a device and software service that detects breast tissue abnormalities leading to health risk assessment and management including early breast cancer identification. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes when compared to other diagnostic protocols. Cyrcadia Health technology is exclusively licensed for development, manufacturing and marketing worldwide from Lifeline Biotechnologies, Inc (OTC Market: LLBO).

Cyrcadia Health is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS product. Cyrcadia Health is preparing to apply for a Euro CE Mark to market in the European Union and Asia Pacific markets.

On March 12 LLBO updates the meaningful activities for First Quarter of 2015: In 2008 Lifeline Biotechnologies exclusively licensed its First Warning Systems technology to First Warning Systems, Inc., (now called Cyrcadia Health) via a revenue royalty license of its patented, circadian rhythm based, pattern recognition technology. Three rounds of proof of concept trials were conducted and validated by the foremost pattern recognition engineers in the world (the Engineers at Nanyang Technological University in Singapore).

RECENT NEWS:http://finance.yahoo.com/news/lifeline-biotechnologies-llbo-q1-2015-171609507.html
]]

BARCHART INDICATOR'S OPINION (100% BUY SHORT,MEDIUM AND LONG TERM): http://www.barchart.com/opinions/stocks/LLBO

BARCHART TRADER'S CHEAT SHEET: http://www.barchart.com/cheatsheet.php?sym=LLBO

BREAK .0072 AND WERE HEADING TO SILVER]

LLBO Share Structure: http://www.otcmarkets.com/stock/LLBO/profile

650m FLOAT

HOLY....LOOK AT THE ACCUM/DISP LINE: http://stockcharts.com/h-sc/ui?s=LLBO&p=W...9569738426


KNOW WHAT U OWN SO YOU CAN MAKE INFORMED FINANCIAL DECISIONS. LOAD AND HOLD IMO
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 291

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 201

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 192

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 249

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 298

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 193

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 158

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 190

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding State Resilience Against Future Economic Challenges

Updated Category News Views 119

States Vulnerable to Economic Downturns The landscape of economic stability is shifting, and many residents might be unaware of how their home states rank in terms of recession preparedness. Recent analyses reveal striking differences in resilience that could significantly impact everyday Americans. With numerous warnings about incoming economic turbulence, it’s crucial...

Continue Reading
Liquidia's Milestone Funding for YUTREPIA™ Sales Surge

Updated Category News Views 334

Liquidia Corporation Announces Significant Funding Boost Liquidia Corporation (NASDAQ: LQDA), a prominent biopharmaceutical company, is thrilled to announce that it has secured an additional $50 million to support the launch of its innovative treatment, YUTREPIA™. This exciting development follows a pivotal legal victory where a U.S. District Court ruled against a...

Continue Reading
Paratus Energy Services Ltd. Reports Mandatory Trade Update

Updated Category News Views 189

Paratus Energy Services Ltd. Reports Mandatory Trade Notification Paratus Energy Services Ltd. has recently announced a significant trade notification involving a close associate of one of its board members. The company, which operates in the energy sector, has revealed that a fund managed by Lodbrok Capital LLP has completed a trade involving its shares. This information...

Continue Reading
Angel Launches Global Theatrical Release of David Musical

Updated Category News Views 181

Angel's Global Release of David Musical Animated musical builds powerful momentum as early domestic pre-sales surge close to $6 million Angel (NYSE: ANGX), a leading media and technology company championing values-driven stories, is setting the stage for the theatrical release of the eagerly awaited animated musical David across 43 international markets. This significant...

Continue Reading
LifeMD, Inc. Announces Exciting Dividend for Shareholders

Updated Category News Views 116

LifeMD, Inc. Announces Quarterly Dividend LifeMD, Inc. (NASDAQ: LFMD), recognized for its pioneering virtual primary care offerings, has announced an important cash dividend for its shareholders. The Company's Board of Directors has declared a cash dividend of $0.5546875 per share on the 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ: LFMDP). This...

Continue Reading